Avanir Pharmaceuticals Inc (AVNR.OQ)

AVNR.OQ on NASDAQ Stock Exchange Global Select Market

4.76USD
10:56am EDT
Price Change (% chg)

$0.05 (+1.06%)
Prev Close
$4.71
Open
$4.74
Day's High
$4.83
Day's Low
$4.72
Volume
64,289
Avg. Vol
447,160
52-wk High
$5.09
52-wk Low
$2.07

AVNR.OQ

Chart for AVNR.OQ

About

AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its... (more)

Overall

Beta: 1.84
Market Cap (Mil.): $682.74
Shares Outstanding (Mil.): 145.11
Dividend: --
Yield (%): --

Financials

  AVNR.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.40 -- --
ROI: -94.51 -2.58 18.76
ROE: -121.06 -2.66 19.59
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF66.60 +0.35
Pfizer Inc. (PFE.N) $29.19 -0.04
Johnson & Johnson (JNJ.N) $93.84 +0.34
Merck & Co., Inc. (MRK.N) $48.10 -0.07
Bayer AG (BAYGn.DE) €89.10 +1.75
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks